FDA PMA FDA Class 3 Approved 🇺🇸 United States

Bone Grafting Material, Dental, With Biologic Component

PMA: P040013 · Supplement: S024 · Decision Dec 4, 2020
Classifications
1
FEI Numbers
6
Registration Numbers
6

Basic Information

Device Name
Bone Grafting Material, Dental, With Biologic Component
Trade Name
GEM21S Growth Factor Enhanced Matrix
PMA Number
P040013
Supplement Number
S024
Device Class
FDA Class 3
Product Code
NPZ
Generic Name
Bone grafting material, dental, with biologic component
Regulation Number
872.3930
Medical Specialty
Dental
Advisory Committee
Dental
Decision
Approved
Decision Code
APPR
Decision Date
December 4, 2020
Date Received
April 17, 2020
Supplement Type
Normal 180 Day Track No User Fee
Supplement Reason
Location Change - Manufacturer/Sterilizer/Packager/Supplier
Expedited Review
N

Advisory Committee Statement

Change in supplier for the formulation, filling, and testing (with the exception of the Bioassay) of the rhPDGF-BB syringe component of GEM21S Growth Factor Enhanced Matrix to a manufacturing site located at Pyramid Laboratories, Inc., 3598 Cadillac Ave., Costa Mesa, CA 92626.

Classifications

This FDA Pre-Market Approval entry is associated with 1 FDA classification via its product code.

Product Code Device Name
NPZ Bone Grafting Material, Dental, With Biologic Component